seed
Stage
1
Investors
About
Slatebio develops advanced regulatory T cell therapies aimed at treating autoimmune diseases by leveraging cellular therapy approaches.
Explore Slatebio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.